Floatz logo

Therapeutic Asset Ratings

247 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
c610
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
Idov-Safetm
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
mt027
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
qh101
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
Ysch-01
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CC (40)
Edb-102
Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1C (39)
Anti-Psma Car-Nk
Castration-Resistant Prostate Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
bmd006
Lung Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
ksx01-tcrt cell therapy
Refractory Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101
Brain Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101
Meningeal Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101
Spinal Cord Metastasis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101 cell
Metastatic Malignant Neoplasm In The Brain
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101 cell
Neoplastic Meningitis
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
qh101 cell
Metastatic Malignant Neoplasm In The Spinal Cord
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (39)
bmd006
Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (38)
bt02 monoclonal antibody
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1C (36)
Edb-102
Non-Small Cell Lung Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1C (36)
Idov-Immune
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (34)
Idov-Safetm
Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (34)
Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-Til)
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly P1C (33)
68Ga-grazytracer
Aggressive B-Cell Non-Hodgkin Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/AD (30)
Al18F-NOTA-FAPI
Aggressive B-Cell Non-Hodgkin Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/AD (30)
Al18F-NOTA-grazytracer
Aggressive B-Cell Non-Hodgkin Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/AD (30)
Showing 201 to 225 of 247 assets
PreviousPage 9 of 10Next